In the BioHarmony Drug Report Database

"Preview" Icon

Fenofibric acid

Fibricor (fenofibric acid) is a small molecule pharmaceutical. Fenofibric acid was first approved as Fibricor on 2009-08-14. It is used to treat coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, and hypertriglyceridemia in the USA. It is known to target peroxisome proliferator-activated receptor alpha, chloride channel protein 1, and fatty acid-binding protein, liver. Lipofen’s patent is valid until 2027-08-20 (FDA).

 

Trade Name

 

Fibricor
 

Common Name

 

fenofibric acid
 

ChEMBL ID

 

CHEMBL981
 

Indication

 

coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia
 

Drug Class

 

Antihyperlipidemics (clofibrate type)

Image (chem structure or protein)

Fenofibric acid structure rendering